Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released May 7, 2013, during market hours
10-Q filed May 7, 2013, 37 days after period end · 0001104659-13-038074
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| EPS Diluted | -$0.29 | -$0.32 | -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 7, 2013 · 37 d after period end
3.6% from the close of May 6, 2013 to the close of May 7, 2013, the first after the release.
